DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/15919995
Sources: https://www.ncbi.nlm.nih.gov/pubmed/15919995
CMK is pyrrolopyrimidine derivatives that contained a chloromethyl ketone designed by the University of California. CMK shows potent irreversible inhibition of RSK2 protein kinase in mammalian cells.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: P51812 Gene ID: 6197.0 Gene Symbol: RPS6KA3 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/15919995 |
|||
Target ID: CHEMBL1841 Sources: https://www.ncbi.nlm.nih.gov/pubmed/15919995 |
4.0 µM [IC50] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vitro Use Guide
Sources: https://google.com/patents/WO2005000197A2
Cmk were tested against the Src-family kinase Fyn, which has a threonine gatekeeper, which in principle should recognize the C-5 aromatic substituent of our inhibitors. At a concentration of 30 nM, cmk had no effect on wild-type (WT) Fyn, whereas it rapidly inactivated an engineered Fyn construct containing a cysteine in place of Val285. In the presence of 1 mM ATP, WT Fyn was relatively resistant to cmk, with IC50 values of 18 mM, respectively. In contrast, 100 nM cmk inactivated Val285Cys Fyn in less than 5 min under these conditions.
| Substance Class |
Protein
Created
by
admin
on
Edited
Tue Apr 01 21:23:36 GMT 2025
by
admin
on
Tue Apr 01 21:23:36 GMT 2025
|
| Protein Type | ENZYME |
| Protein Sub Type | |
| Sequence Origin | HUMAN |
| Sequence Type | COMPLETE |
| Record UNII |
I9BC9TJN0M
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
P30085
Created by
admin on Tue Apr 01 21:23:36 GMT 2025 , Edited by admin on Tue Apr 01 21:23:36 GMT 2025
|
PRIMARY | |||
|
EC 2.7.4.14
Created by
admin on Tue Apr 01 21:23:36 GMT 2025 , Edited by admin on Tue Apr 01 21:23:36 GMT 2025
|
PRIMARY | |||
|
I9BC9TJN0M
Created by
admin on Tue Apr 01 21:23:36 GMT 2025 , Edited by admin on Tue Apr 01 21:23:36 GMT 2025
|
PRIMARY | |||
|
CMPK
Created by
admin on Tue Apr 01 21:23:36 GMT 2025 , Edited by admin on Tue Apr 01 21:23:36 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
SUBSTRATE -> METABOLIC ENZYME |
Agent Modifications
| Modification Process | Modification Role | Modification Type | Amount | Fragment Name | Fragment ID |
|---|---|---|---|---|---|
| MOIETY | CHEMICAL |
|
MAGNESIUM CATION | T6V3LHY838 |
Structural Modifications
| Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
|---|---|---|---|---|---|---|
| AMINO_ACID_SUBSTITUTION | [1_106] | SITE_SPECIFIC | N6-SUCCINYLLYSINE | 3LH35AJA5L | ||
| AMINO_ACID_SUBSTITUTION | [1_180] | SITE_SPECIFIC | DEXFOSFOSERINE | VI4F0K069V | ||
| AMINO_ACID_SUBSTITUTION | [1_43] | SITE_SPECIFIC | N6-ACETYLLYSINE | 470AD5VY1X |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Molecular Formula | CHEMICAL |
|
||||
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|